Moderna doubles size of COVID-19 vaccine pediatric study
The Peninsula
Moderna Inc is planning to double the size of an ongoing trial testing its COVID-19 vaccines in children aged six months to less than 12 years.
According to updated details on clinical trial record site clinicaltrials.gov, the study will now enroll an estimated 13,275 participants, nearly double the earlier target of 6,975 participants. In July, Moderna said it was in discussions with the U.S. Food & Drug Administration to expand the study with an objective to enroll a larger safety database, which increases the likelihood of detecting rarer events.
Seoul: Samsung launched its first triple folding phone on Tuesday, a special edition product with an eyewatering price tag placing it out of the reach...
Doha, Qatar: The Safari 10, 20, 30 Promotion has started from December 1 at Safari, one of Doha s leading hypermarket chains. This is one of Safari...
DOHA: Pakistan International School Qatar (PISQ) commemorated Iqbal Day with great passion, respect, and national pride across all its wings, paying t...
Islamic Cultural Center holds lecture on youth empowerment in Islam at Mesaieed International School
Doha, Qatar: With the attendance of 210 students, the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center organised a lecture entitled Youth E...
Doha, Qatar: The Ministry of Public Health (MoPH) has carried out an extensive inspection campaign that included a number of restaurants, cafes, and l...
Washington, USA: Amazon and Google announced the launch of a multi cloud networking service, jointly developed to meet the growing demand for reliable...
Doha, Qatar: Twenty students from the Community College visited the Sheikh Abdulla Bin Zaid Al Mahmoud Islamic Cultural Center, where they learned abo...
London, UK: The Winter egg, one of Faberge s most dazzling creations, is due to be auctioned in London next week and set another sales price record fo...